Computer-Assisted HIV Prevention for Young Drug Users

HIV Clinical Trial

Official title:

Computer-Assisted HIV Prevention for Young Drug Users

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT00182585
• Other study ID #: R01DA015964
• Status: Active, not recruiting
• Phase: N/A
• First received: September 10, 2005
• Last updated: August 11, 2008
• Start date: August 2004

Study information

• Verified date: August 2008
• Source: National Development and Research Institutes, Inc.
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Interventional

Clinical Trial Summary

In this study, the investigators are developing and evaluating an interactive, computer-assisted HIV, STD and disease prevention program for young substance abusers that incorporates effective components of both prevention science and educational technologies.

Description:

Adolescents and young adults who use drugs are at high risk for infection with HIV, STDs and other diseases with similar transmission dynamics. Although several age-appropriate and effective HIV, STD and disease prevention efforts have been identified for young substance abusers, most interventions have been narrow in focus and are generally not structured to readily address changing patterns of drug use among adolescents that place them at risk for infection with these diseases. In this study, we are developing and evaluating an interactive, computer-assisted HIV, STD and disease prevention program for young substance abusers that incorporates effective components of both prevention science and educational technologies. We plan to develop this program with the input from the target population of adolescents and young adults. We also plan to conduct a randomized, controlled trial to evaluate the benefit of including this program in HIV and disease prevention efforts with youth in substance abuse treatment. In so doing, we will evaluate the ability of the program to promote accurate knowledge about HIV and other diseases, promote self-efficacy to reduce risk behavior and change actual rates of risk behavior among young substance abusers. This computer-based program will be designed to promote the increased adoption of effective HIV and disease prevention science for this population. New information about changing patterns of drug use and HIV risk behaviors can be readily incorporated into the program as it becomes available. The program can be easily exported and able to be applied with fidelity. Importantly, the program will be structured such that a therapist or educator may customize the program content for use by various sub-populations of substance-abusing adolescents and young adults. Thus, the program will be able to address risk factors specific to each young drug user. This program may address many of the challenges associated with the current delivery of evidence-based HIV prevention programs to this population.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 56
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 13 Years to 18 Years

Eligibility

Inclusion Criteria:

• Aadolescents in outpatients substance abuse treatment

• Ages 13 - 18 years

• Within first month of treatment entry

Exclusion Criteria:

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• HIV

Intervention

Procedure:
• computer-based HIV, STD & Hepatitis Education

• educator-delivered HIV, STD and Hepatitis education

Locations

Country	Name	City	State
United States	Daytop	Brooklyn	New York
United States	St. Luke's-Hospital, CAPA Program	New York	New York

Sponsors (3)

Lead Sponsor	Collaborator
National Development and Research Institutes, Inc.	Daytop (adolescent treament program), St. Luke's-Roosevelt Hospital Center

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	HIV risk behavior
Secondary	knowledge related to HIV, Hepatitis, STDs
Secondary	behavioral intentions
Secondary	attitudes toward risk-reduction behavior
Secondary	feedback on intervention